Skip to main content

Vestal Point Capital, LP

Position in BCAX — Bicara Therapeutics Inc.

CIK 1974915 NEW YORK, NY

Position in BCAX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$155,872,500
+$47,969,250 QoQ
Shares Held
5,250,000
-3.2% QoQ
Ownership
7.93%
of shares outstanding
% of Portfolio
3.64%
of 13F equity value
Holder Rank
#4
of 169 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Vestal Point Capital, LP holds $2,824,321,683 across 51 Biotechnology names. BCAX ranks #5 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 BCAX
Bicara Therapeutics Inc.
This page
5,250,000 $155,872,500

All Filings in BCAX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $155,872,500 5,250,000
2026-03-31 $107,903,250 5,425,000
2025-12-31 $60,167,250 3,575,000
2025-09-30 $80,529,000 5,100,000
2025-06-30 $46,450,000 5,000,000
2025-03-31 $36,079,744 2,768,975
2025-03-31 $36,079,744 2,768,975
2024-12-31 $12,368,200 710,000
2024-09-30 $10,824,750 425,000